Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran
Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S.
Haematologica 88(4): Elt13
2003
ISSN/ISBN: 0390-6078 PMID: 12681990 Document Number: 553499
Document emailed within 1 workday
Related Documents
Powles, R.; Mehta, J.; Singhal, S.; Horton, C.; Tait, D.; Milan, S.; Pollard, C.; Lumley, H.; Matthey, F.; Shirley, J. 1995: Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center Bone Marrow Transplantation 16(2): 241-247Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
del Rosario Uriarte, M.; Bonomi, R.; Azambuja, C.; Seuánez, H.N. 1997: Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia Leukemia 11(12): 2213-2214
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Benesová, P.; Dĕdic, K.; Zák, P.; Voglová, J. 2004: Complete regression of bone marrow fibrosis following allogeneic peripheral blood stem cell transplantation in a patient with idiopathic myelofibrosis Ceskoslovenska Patologie 40(4): 167-171
Lin, Y.T.; Lin, D.T.; Jou, S.T.; Lin, K.S.; Lin, K.H. 1997: Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood Journal of the Formosan Medical Association 96(5): 320-324
Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O. 2002: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87(8): 894-896
Mazza, P.; Amurri, B.; Palazzo, G.; Prudenzano, A.; Pricolo, G.; Stani, L. 2000: Fludarabine containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience Haematologica 85(2): 222-224
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Weisser, M.; Tischer, J.; Schnittger, S.; Schoch, C.; Ledderose, G.; Kolb, H.Jochem. 2006: A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation Haematologica 91(5): 663-666
Huang, X.; Wang, F.; Guo, N. 2001: Allogeneic peripheral blood stem cell transplantation for high-risk leukemia Zhonghua Yi Xue Za Zhi 81(22): 1348-1351
Brinch, L.; Tjønnfjord, G.; Gedde-Dahl, T.; Heldal, D.; Holme, Pål.André.; Dybedal, I. 2008: Allogeneic stem cell transplantation in acute myelogenous leukemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(15): 1681-2; Author Reply 1682
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Salat, C.; Holler, E.; Hiller, E.; Pihusch, R.; Kolb, H.J. 1999: Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation Haematologica 84 Suppl Eha-4: 40-43
Rao, S.G.; Kothari, V.; Nadkarni, K.; Ahuja, H.; Advani, S. 1987: Evidence for the presence in sera from chronic myelogenous leukemia patients of an activity that enhances the number of normal bone marrow-derived granulocyte/monocyte committed stem cell colonies Nouvelle Revue Francaise d'Hematologie 29(4): 231-236
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Cunningham, I. 1990: Bone marrow transplantation for chronic myelogenous leukemia Oncology 4(11): 101-108; Discussion 108, 111
Appelbaum, F.R.; Clift, R.; Radich, J.; Anasetti, C.; Buckner, C.D. 1995: Bone marrow transplantation for chronic myelogenous leukemia Seminars in Oncology 22(4): 405-411